ASSOCIATIONS BETWEEN ETHNICITY, BIOCHEMICAL DISEASE SEVERITY, AND LIVER TRANSPLANT-FREE SURVIVAL IN CANADIAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

被引:0
|
作者
Roberts, Surain B. [1 ,2 ]
Worobetz, Lawrence [3 ]
Vincent, Catherine [4 ]
Flemming, Jennifer A. [5 ]
Tsien, Cynthia [6 ]
Qumosani, Karim M. [7 ]
Swain, Mark Gordon [8 ]
Grbic, Dusanka [9 ]
Ko, Hin Hin [10 ]
Peltekian, Kevork M. [11 ]
Selzner, Nazia [12 ]
Abrahamyan, Lusine [1 ]
Aziz, Bishoi [13 ]
Lytvyak, Ellina [13 ]
Tirona, Kattleya [2 ]
Gulamhusein, Aliya F. [1 ]
Janssen, Harry L. A. [14 ]
Montano-Loza, Aldo J. [13 ]
Hirschfield, Gideon [2 ]
Mason, Andrew L. [13 ]
Hansen, Bettina E. [15 ,16 ,17 ]
机构
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto Gen Hosp, Toronto, ON, Canada
[3] Royal Univ Hosp, Saskatoon, SK, Canada
[4] Univ Montreal, Dept Med, Montreal, PQ, Canada
[5] Queens Univ, Med, Kingston, ON, Canada
[6] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[7] Western Univ, London, England
[8] Univ Calgary, Med, Calgary, AB, Canada
[9] Univ Sherbrooke, Sherbrooke, PQ, Canada
[10] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada
[11] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[12] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[13] Univ Alberta, Div Gastroenterol & Liver Unit, Edmonton, AB, Canada
[14] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[15] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
[16] Toronto Gen Hosp, Toronto, ON, Canada
[17] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
108
引用
收藏
页码:73A / 74A
页数:2
相关论文
共 50 条
  • [21] Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
    Amandeep K. Dhillon
    Andreas E. Kremer
    Martin Kummen
    Kirsten M. Boberg
    Ronald P. Oude Elferink
    Tom H. Karlsen
    Ulrich Beuers
    Mette Vesterhus
    Johannes R. Hov
    Scientific Reports, 9
  • [22] A dose-response relationship in the association between ursodeoxycholic acid treatment and prolonged transplant-free survival in primary biliary cholangitis
    Van der Meer, A.
    Harms, M.
    Lammers, W. J.
    Corpechot, C.
    Thorburn, D.
    Invernizzi, P.
    Janssen, H.
    Battezzati, P. M.
    Nevens, F.
    Lindor, K.
    Floreani, A.
    Ponsioen, C.
    Mayo, M. J.
    Pares, A.
    Mason, A. L.
    Kowdley, K. V.
    Hirschfield, G.
    Van Buuren, H.
    Hansen, B.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S230 - S230
  • [23] VITAMIN D SUPPLEMENTATION IS ASSOCIATED WITH LIVER TRANSPLANT-FREE AND HEPATOBILIARY MALIGNANCY-FREE SURVIVAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Mulligan, Connor
    Pratt, Henry
    Mitsialis, Vanessa
    Pratt, Daniel S.
    HEPATOLOGY, 2021, 74 : 788A - 789A
  • [24] Ursodeoxycholic Acid is Associated with a Prolonged Transplant-free Survival in All Patients with Primary Biliary Cholangitis - there is no such thing as non-response.
    van der Meer, Adriaan J.
    Harms, Maren H.
    Corpechot, Christophe
    Thorburn, Douglas
    Lammers, Willem J.
    Invernizzi, Pietro
    Janssen, Harry L.
    Battezzati, Pier Maria
    Nevens, Frederik
    Lindor, Keith D.
    Floreani, Annarosa
    Ponsioen, Cyriel Y.
    Mayo, Marlyn J.
    Pares, Albert
    Mason, Andrew
    Kowdley, Kris V.
    Hirschfield, Gideon M.
    van Buuren, Henk R.
    Hansen, Bettina E.
    HEPATOLOGY, 2017, 66 : 155A - 155A
  • [25] NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVAL
    Vesterhus, M.
    Holm, A.
    Hov, J. R.
    Andersen, I. M.
    Schrumpf, E.
    Paulsen, V.
    Bjornstad, M.
    Lundin, K.
    Zweers, S. J. L. B.
    Vatn, M.
    Schaap, F. G.
    Ueland, T.
    Rosjo, H.
    Moum, B.
    Ponsioen, C. Y.
    Boberg, K. M.
    Farkkila, M.
    Lund-Johansen, F.
    Karlsen, T. H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S55 - S56
  • [26] Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid
    Cheung, Ka-Shing
    Seto, Wai-Kay
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8
  • [27] INTRAMUSCLE FAT FRACTION INDEPENDENTLY PREDICTS TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Praktiknjo, Michael
    Zhou, Taotao
    Kruesken, Maximiliane
    Chang, Johannes
    Sprinkart, Alois Martin
    Dold, Leona
    Luetkens, Julian
    Jansen, Christian
    Strassburg, Christian P.
    Weismueller, Tobias J.
    HEPATOLOGY, 2021, 74 : 768A - 769A
  • [28] Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
    Bossen, Lars
    Vesterhus, Mette
    Hov, Johannes R.
    Farkkila, Martti
    Rosenberg, William M.
    Moller, Holger J.
    Boberg, Kirsten M.
    Karlsen, Tom H.
    Gronbaek, Henning
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (03) : e00315
  • [29] A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY
    Goode, Elizabeth C.
    Hirschfield, Gideon M.
    Rushbrook, Simon M.
    HEPATOLOGY, 2020, 71 (01) : 399 - 400
  • [30] IMAGING-BASED ASSESSMENT OF SARCOPENIA PREDICTS TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Seifert, Leon Louis
    Keshoofi, Pedram
    Schindler, Philipp
    Rennebaum, Florian
    Cordes, Friederike
    Morgul, Haluk
    Wildgruber, Moritz
    Heinzow, Hauke
    Trebicka, Jonel
    Husing-Kabar, Anna
    HEPATOLOGY, 2022, 76 : S1478 - S1479